Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
John Marshall Bancorp | JMSB | Sep 25, 2024 | 19.57 | +3.55 |
John Wiley & Sons A | WLY | Sep 25, 2024 | 45.83 | -2.47 |
John Wiley & Sons B | WLYB | Sep 25, 2024 | 46.76 | 0.00 |
Johnson & Johnson | JNJ | Sep 25, 2024 | 160.60 | -1.34 |
Johnson Controls International | JCI | Sep 25, 2024 | 75.83 | +0.37 |
Johnson Outdoors A | JOUT | Sep 25, 2024 | 35.99 | -1.72 |
Joint Stock Company Kaspi.kz | KSPI | Sep 25, 2024 | 106.24 | +1.69 |
Jones Lang LaSalle | JLL | Sep 25, 2024 | 267.31 | -0.79 |
Journey Medical | DERM | Sep 25, 2024 | 5.42 | +4.23 |
Jowell Global | JWEL | Sep 25, 2024 | 1.45 | +1.44 |
JOYY ADR | YY | Sep 25, 2024 | 36.33 | -1.17 |
JP Morgan Chase | JPM | Sep 25, 2024 | 210.19 | -0.66 |
JP Morgan Chase & Co EE Pref | JPM-C | Sep 25, 2024 | 25.72 | -0.12 |
JP Morgan Chase & Co GG Pref | JPM-J | Sep 25, 2024 | 23.88 | -0.13 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Sep 25, 2024 | 25.55 | 0.00 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Sep 25, 2024 | 54.73 | +0.04 |
Jumia Technologies ADR | JMIA | Sep 25, 2024 | 4.66 | +0.43 |
Junee Limited - Ordinary Shares | JUNE | Sep 25, 2024 | 4.36 | -10.10 |
Junior Gold Miners ETF Market Vectors | GDXJ | Sep 25, 2024 | 50.53 | -1.15 |
Juniper Networks | JNPR | Sep 25, 2024 | 38.85 | +0.10 |
JVSPAC Acquisition | JVSA | Sep 25, 2024 | 10.33 | -0.05 |
JVSPAC Acquisition | JVSAU | Sep 25, 2024 | 10.64 | 0.00 |
JX Luxventure | JXJT | Sep 25, 2024 | 1.91 | -0.26 |
Kadant | KAI | Sep 25, 2024 | 332.90 | -2.10 |
Kairos Pharma | KAPA | Sep 25, 2024 | 1.86 | 0.00 |
Kairous Acquisition | KACL | Sep 25, 2024 | 12.20 | 0.00 |
Kaiser Aluminium | KALU | Sep 25, 2024 | 70.22 | -2.27 |
Kaival Brands Innovations Group | KAVL | Sep 25, 2024 | 1.10 | -5.98 |
Kaixin Auto | KXIN | Sep 25, 2024 | 0.08 | +7.63 |
Kala Bio | KALA | Sep 25, 2024 | 5.46 | -1.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.